Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 24 Carcinoma, Intraductal, Noninfiltrating 6 Breast Carcinoma In Situ 3 Neoplasms 2 Endometrial Neoplasms 2 Breast Neoplasms, Male 2 Breast Diseases 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rhabdoid Tumor 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Pinealoma 1 Pancreatic Neoplasms 1 Pancreatic Cyst 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Medulloblastoma 1 Infertility 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 HR Positive HER2 Negative Advanced Breast Cancer 1 Glioblastoma 1 ERα+ Breast Cancer 1 ER+ Breast Cancer 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

palbociclib 1 exemestane 1 elacestrant 1 Tamoxifen 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × ER+ Breast Cancer × Tamoxifen × Clear all

NCT04985266 2024-12-05

TRAK-ER

Royal Marsden NHS Foundation Trust

Phase 2 Recruiting

ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡